Skip to content

IH LIFE SCIENCES

Active
Private limited companyfounded 2018active for 8 yearsHeikant 266, 9240 Zele, BelgiumKBO/BCE: BE 0687.864.810
Summary

IH LIFE SCIENCES has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €377,493 and a net result of €3,459. Equity is growing by about 4.3% per year across the filed financial years. Its solvency ranks better than 63% of 20,330 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Financials · financial year 2025, micro format

Equity
€377,493▲ 0.9%
2024 · €374,034
Total assets
€503,586▲ 33.6%
2024 · €376,955
Net result
€3,459
2024 · -€40,797
Working capital
-€69,564
2024 · €341,866
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 7 financial years

The operating result stays negative: a loss of €1,766 in 2025 against €19,520 in 2024; the loss shrinks.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€1,766 2025 Net result€3,459 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2019202020212022202320242025
Operating result€223,743-€171,754▼ 23.2%€193,385▲ 12.6%€4,076▼ 97.9%-€25,353-€19,520▲ 23.0%-€1,766▲ 91.0%
Net result€159,480-€125,858above the sector's middle half▼ 21.1%€145,470above the sector's middle half▲ 15.6%€1,755below the sector's middle half▼ 98.8%-€26,909below the sector's middle half-€40,797below the sector's middle half▼ 51.6%€3,459below the sector's middle half
Equity€171,880-€296,115within the sector's middle half▲ 72.3%€439,985above the sector's middle half▲ 48.6%€441,739above the sector's middle half▲ 0.4%€414,831above the sector's middle half▼ 6.1%€374,034within the sector's middle half▼ 9.8%€377,493above the sector's middle half▲ 0.9%
Total assets€237,783-€350,302within the sector's middle half▲ 47.3%€498,341within the sector's middle half▲ 42.3%€447,357within the sector's middle half▼ 10.2%€416,477within the sector's middle half▼ 6.9%€376,955within the sector's middle half▼ 9.5%€503,586within the sector's middle half▲ 33.6%
Debt€65,902-€54,187▼ 17.8%€58,357▲ 7.7%€5,617▼ 90.4%€1,646▼ 70.7%€2,921▲ 77.4%€126,093▲ 4,217%
Working capital€171,306-€258,474above the sector's middle half▲ 50.9%€398,126above the sector's middle half▲ 54.0%€401,418above the sector's middle half▲ 0.8%€376,808above the sector's middle half▼ 6.1%€341,866above the sector's middle half▼ 9.3%-€69,564below the sector's middle half
Solvency72.3%-84.5%above the sector's middle half▲ 12.2pp88.3%above the sector's middle half▲ 3.8pp98.7%above the sector's middle half▲ 10.5pp99.6%above the sector's middle half▲ 0.9pp99.2%above the sector's middle half▼ 0.4pp75.0%within the sector's middle half▼ 24.3pp
Current ratio3.60-5.77within the sector's middle half▲ 2.177.82above the sector's middle half▲ 2.0572.46above the sector's middle half▲ 64.640.45below the sector's middle half
Return on assets (ROA)67.1%-35.9%above the sector's middle half▼ 31.1pp29.2%within the sector's middle half▼ 6.7pp0.4%below the sector's middle half▼ 28.8pp-6.5%below the sector's middle half▼ 6.9pp-10.8%below the sector's middle half▼ 4.4pp0.7%below the sector's middle half▲ 11.5pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €503,586
Fixed assets €447,118 ▲ 1,290%
Current assets €56,469 ▼ 83.6%
Equity and liabilities €503,586
Equity €377,493 ▲ 0.9%
Debt €126,093 ▲ 4,217%
Debt's share of the balance-sheet total rises from 0.8% to 25.0%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€24,696▲
2024 · -€13,666
Cash flow
€29,922▲
2024 · -€34,942
Debt to equity
0.33▲
2024 · 0.01
ROE
0.9%▲
2024 · -10.9%
Interest coverage
19.11▲
2024 · -9.01
Debt ≤ 1 year
€126,032▲
2024 · €2,921
Income taxes
-€4,201▼
2024 · €22,216
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,640 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 95.5% are still going.

  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
0.5% went bankrupt
3.6% stopped otherwise
95.5% still going

A further 0.3% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,468 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,640 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€376,955€503,586▲
Fixed assets21/28€32,168€447,118▲
Tangible fixed assets22/27€32,168€447,118▲
Land and buildings22-€420,805
Other tangible fixed assets26€32,168€26,313▼
Current assets29/58€344,787€56,469▼
Amounts receivable within one year40/41€56,326€879▼
Trade receivables40€0€125▲
Other amounts receivable41€56,326€754▼
Current investments50/53€15,000€15,000=
Cash at bank and in hand54/58€266,623€35,215▼
Deferred charges and accrued income490/1€6,838€5,374▼
Equity and liabilities
Total equity and liabilities10/49€376,955€503,586▲
Equity10/15€374,034€377,493▲
Contributions10/11€12,400€12,400=
Reserves13€361,634€365,093▲
Tax-exempt reserves132€0-
Distributable reserves133€361,634€365,093▲
Amounts payable17/49€2,921€126,093▲
Amounts payable within one year42/48€2,921€126,032▲
Financial debts43€200€0▼
Credit institutions430/8€200€0▼
Trade debts44€1,639€1,956▲
Suppliers440/4€1,639€1,956▲
Taxes, remuneration and social security45€1,082€1,811▲
Taxes450/3€1,082€1,811▲
Other amounts payable47/48-€122,265
Accrued charges and deferred income492/3-€61
Income statement Code20242025
Non-recurring operating income76A-€28,082
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5,855€26,463▲
Other operating charges640/8€375€352▼
Gross operating margin9900-€13,291€25,048▲
Operating profit (loss)9901-€19,520-€1,766▲
Financial income75/76B€2,456€2,316▼
Recurring financial income75€2,456€2,316▼
Financial charges65/66B€1,516€1,292▼
Recurring financial charges65€1,516€1,292▼
Profit (loss) for the period before taxes9903-€18,581-€742▲
Income taxes67/77€22,216-€4,201▼
Profit (loss) for the period9904-€40,797€3,459▲
Transfer from tax-exempt reserves789€134,350€0▼
Profit (loss) for the period to be appropriated9905€93,553€3,459▼
Appropriation of the result
Profit (loss) to be appropriated9906€93,553€3,459▼
Transfer from equity791/2€0-
Transfer to equity691/2€93,553€3,459▼
To other reserves6921€93,553€3,459▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2019202020212022202320242025Change
Non-recurring operating income76A------€28,082-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,711€2,420€4,735€5,402€5,746€5,855€26,463▲ 352%
Other operating charges640/8--€518€172€248€375€352▼ 6.1%
Non-recurring operating charges66A--€563€0----
Gross operating margin9900€226,453€174,293€199,201€9,650-€19,359-€13,291€25,048-
Operating profit (loss)9901€223,743€171,754€193,385€4,076-€25,353-€19,520-€1,766▲ 91.0%
Financial income75/76B--€2,152€777€852€2,456€2,316▼ 5.7%
Recurring financial income75€216€562€2,152€777€852€2,456€2,316▼ 5.7%
Financial charges65/66B--€1,678€1,776€1,570€1,516€1,292▼ 14.8%
Recurring financial charges65€2,165€1,678€1,678€1,776€1,570€1,516€1,292▼ 14.8%
Profit (loss) for the period before taxes9903€221,793€170,638€193,859€3,077-€26,071-€18,581-€742▲ 96.0%
Income taxes67/77€62,313€44,780€48,389€1,322€837€22,216-€4,201-
Profit (loss) for the period9904€159,480€125,858€145,470€1,755-€26,909-€40,797€3,459-
Transfer from tax-exempt reserves789-----€134,350€0▼ 100%
Transfer to tax-exempt reserves689--€63,150€0----
Profit (loss) for the period to be appropriated9905€88,280€125,858€82,320€1,755-€26,909€93,553€3,459▼ 96.3%
Line2019202020212022202320242025Change
Assets
Total assets20/58€237,783€350,302€498,341€447,357€416,477€376,955€503,586▲ 33.6%
Fixed assets21/28€607€37,640€41,859€40,321€38,023€32,168€447,118▲ 1,290%
Tangible fixed assets22/27€607€37,640€41,859€40,321€38,023€32,168€447,118▲ 1,290%
Land and buildings22------€420,805-
Plant, machinery and equipment23--€0-----
Furniture and vehicles24--€0-----
Other tangible fixed assets26--€41,859€40,321€38,023€32,168€26,313▼ 18.2%
Current assets29/58€237,176€312,662€456,482€407,036€378,454€344,787€56,469▼ 83.6%
Amounts receivable within one year40/41€28,132€33,862€32,838€17,587€31,726€56,326€879▼ 98.4%
Trade receivables40--€23,814€50€2,073€0€125-
Other amounts receivable41--€9,024€17,537€29,653€56,326€754▼ 98.7%
Current investments50/53----€15,000€15,000€15,000=
Cash at bank and in hand54/58€206,338€274,750€421,582€389,146€323,156€266,623€35,215▼ 86.8%
Deferred charges and accrued income490/1--€2,062€302€8,572€6,838€5,374▼ 21.4%
Equity and liabilities
Total equity and liabilities10/49€237,783€350,302€498,341€447,357€416,477€376,955€503,586▲ 33.6%
Equity10/15€171,880€296,115€439,985€441,739€414,831€374,034€377,493▲ 0.9%
Contributions10/11€12,400-€12,400€12,400€12,400€12,400€12,400=
Reserves13€159,480€283,715€427,585€429,339€402,431€361,634€365,093▲ 1.0%
Non-distributable reserves130/1--€1,860€1,860€0---
Reserves not available under the articles1311--€1,860€1,860€0---
Tax-exempt reserves132--€134,350€134,350€134,350€0--
Distributable reserves133--€291,375€293,129€268,081€361,634€365,093▲ 1.0%
Profit (loss) carried forward14--€0€0----
Amounts payable17/49€65,902€54,187€58,357€5,617€1,646€2,921€126,093▲ 4,217%
Amounts payable within one year42/48€65,870€54,187€58,357€5,617€1,646€2,921€126,032▲ 4,215%
Financial debts43---€257€20€200€0▼ 100%
Credit institutions430/8---€257€20€200€0▼ 100%
Trade debts44€3,433€5,153€5,562€4,845€208€1,639€1,956▲ 19.4%
Suppliers440/4--€5,562€4,845€208€1,639€1,956▲ 19.4%
Taxes, remuneration and social security45--€37,794€515€1,418€1,082€1,811▲ 67.4%
Taxes450/3--€37,794€515€1,418€1,082€1,811▲ 67.4%
Other amounts payable47/48--€15,000€0--€122,265-
Accrued charges and deferred income492/3------€61-
Line2019202020212022202320242025Change
Profit (loss) for the period9904€159,480€125,858€145,470€1,755-€26,909-€40,797€3,459-
+ Depreciation and write-downs630€2,711€2,420€4,735€5,402€5,746€5,855€26,463▲ 352%
Operating cash flow (approximation)€162,191€128,278€150,205€7,157-€21,162-€34,942€29,922-
Investment in fixed assets (approximation)--€39,453-€8,954-€3,864-€3,448€0-€441,413-
Change in cash-€68,412€146,832-€32,436-€65,990-€56,533-€231,408▼ 309%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (7)
Financial year Type Filed Reference
30-09-2025 micro format 30-04-2026 2026-00094723
30-09-2024 micro format 07-05-2025 2025-00089974
30-09-2023 micro format 24-04-2024 2024-00069120
30-09-2022 micro format 21-04-2023 2023-00065739
30-09-2021 micro format 28-04-2022 2022-20019860
30-09-2020 micro format 29-04-2021 2021-12700033
30-09-2019 micro format 16-04-2020 2020-09200473

Similar companies · same sector, comparable size

Of the 694 active companies whose main activity is medical imaging and medical laboratories (NACE 86910), figures are known for 524. 417 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.